Sudhanva S. Kashyap

Sudhanva S. Kashyap

Auto-generated profile, based on publicly available information

Sudhanva S. Kashyap

Iowa State Univ, Coll Vet Med, Dept Biomed Sci, Ames, IA 50011 USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2021 in International Journal for Parasitology: Drugs and Drug Resistance
Verified
Journal Article
Open access
SCShivani Choudhary
Shivani Choudhary
SKSudhanva S. Kashyap
Sudhanva S. Kashyap
RMRichard Martin
Richard Martin
ARAlan Robertson
Alan Robertson
Ion channels are specialized multimeric proteins that underlie cell excitability. These channels integrate with a variety of neuromuscular and biological functions. In nematodes, the physiological behaviors including locomotion, navigation, feeding and reproduction, are regulated by these protein entities. Majority of the antinematodal chemotherapeutics target the ion channels to disrupt essential biological functions. Here, we have summarized current advances in our understanding of nematode ion channel pharmacology. We review cys-loop ligand gated ion channels (LGICs), including nicotinic acetylcholine receptors (nAChRs), acetylcholine-chloride gated ion channels (ACCs), glutamate-gated chloride channels (GluCls), and GABA (γ-aminobutyric acid) receptors, and other ionotropic receptors (transient receptor potential (TRP) channels and potassium ion channels). We have provided an update on the pharmacological properties of these channels from various nematodes. This article catalogs the differences in ion channel composition and resulting pharmacology in the phylum Nematoda. This diversity in ion channel subunit repertoire and pharmacology emphasizes the importance of pursuing species-specific drug target research. In this review, we have provided an overview of recent advances in techniques and functional assays available for screening ion channel properties and their application.

29 October 2022 in International Journal for Parasitology: Drugs and Drug Resistance
Verified
Journal Article
Open access
SKSudhanva S. Kashyap
Sudhanva S. Kashyap
MMMark A. McHugh
Mark A. McHugh
ARAlan P. Robertson
Alan P. Robertson
RMRichard Martin
Richard Martin
Human and veterinary filarial nematode infections are a major health concern in tropical countries. They are transmitted by biting insects and mosquitoes. Lymphatic filariasis, a group of filarial infections caused by Brugia spp. and Wucheria bancrofti affect more than 120 million people worldwide. Infected individuals develop swollen limbs and disfigurement, leading to an inability to work and ostracization from society. Control and prophylaxis for these infections involve mass drug administration combinations of anthelmintics including diethylcarbamazine (DEC). DEC has actions on microfilariae, but its effects on adult worms are less pro-nounced. The SLO-1 (BK) channel activator, emodepside, kills adults of many filarial species. However, the in vivo efficacy of emodepside is suboptimal against B. malayi, possibly due to reduced bioavailability in the lymphatic system. Expressing different slo-1 splice variants in B. malayi also affects sensitivity to emodepside. This study explores the potentiation of emodepside mediated paralysis by DEC in adult female B. malayi. Worminator motility measurements show that co-application of DEC and emodepside increases the potency of emodepside 4-fold. The potentiation of the emodepside effect persists even after the worms recover (desensitize) from the initial effects of DEC. RNAi knock-down demonstrates that the DEC-mediated potentiation of emodepside requires the presence of TRP-2 channels. Our study demonstrates that the addition of DEC could enhance the effect of emodepside where bioavailability or activity against a specific species may be low.

20 April 2022 in microPublication Biology
Verified
Journal Article
Open access
RDReal Datta
Real Datta
ARAlan Robertson
Alan Robertson
RMRichard Martin
Richard Martin
SKSudhanva Kashyap
Sudhanva Kashyap
Diethylcarbamazine (DEC) has been used to treat lymphatic filariasis in tropical countries since the 1940s. Its mode of action is still unclear, with several reports suggesting a host immune system-mediated mechanism. We previously demonstrated that DEC causes transient spastic paralysis in the filarial nematode Brugia malayi due to the activation of TRP-2. Here we show that DEC causes transient paralysis in C. elegans at high concentrations and is 200x less potent compared to its effect on B. malayi. C. elegans trp-2(sy691) mutants are like the wild-type and only paralyzed by high concentrations of DEC. Our results demonstrate that high concentrations of DEC cause paralysis of C. elegans independent of TRP-2.